"I truly enjoyed PEGS Boston. There was an excellent balance of topics and academic vs pharma vs biotech. If anything, the challenge was that often I wanted to be two places at once, good that everything will be available on demand. There was plenty to keep me busy the whole time. Posters were also very well selected."
Pietro S., PhD, Group Leader, Royal Society University Research Fellow, Chemistry of Health, Yusuf Hamied Department of Chemistry, University of Cambridge
“Of all the major biomedical research meetings I have been to, I have to say that PEGS is still my favorite. I am biased since I love to get into the weeds of all things within protein and cell engineering.”
Mahiuddin A., PhD, President and CSO, VITRUVIAE
"It was truly a pleasure to participate in such a dynamic and well-curated event. I thoroughly enjoyed the conference and appreciated the opportunity to contribute. I was particularly happy to see the convergence of T-cell engager (TCE) and allogeneic T-cell work, which is an area of great interest for us. I also want to highlight how valuable the exhibition was, several vendors I met there will likely play a key role in supporting our upcoming projects. The scale and diversity of the talks were impressive. The unique convergence of biomolecules, machine learning, and cell engineering makes it stand out. I also appreciated the clear focus on translational potential throughout the sessions."
Riyaz K., PhD Candidate, T Cell Therapies, ETH Zurich
"I enjoyed the discussions during networking sessions. It was a great way to connect with others and learn more about the field. It was interesting to learn what companies are most interested in and what they think are the main challenges. I also enjoyed the organised “young scientist meetup”, where I met many others in a similar career stage. The strong attendance by companies was different from other meetings/events I have attended."
Henriette C., PhD Student, University of Oxford
"PEGS provides a truly unique opportunity to put scientists together. Its networking power even had me run into my undergraduate research advisor for the first time since undergrad 20 years ago!"
Rob D., Technical Representative, CovalX
"PEGS is always a wonderful experience. It's an opportunity to connect with colleagues and peers as well as a chance to see the pulse of the industry."
Jacob W., Scientific Consultant, Genedata
"I found PEGS to be incredibly valuable and highly relevant to my role as a scientist in the pharmaceutical industry. It gave me an industry-wide perspective on current trends and state-of-the-art technologies in the field of drug design, development and analytics."
Mahalia S., Principal Scientist, Bristol Myers Squibb
"From philosophical to practical and even instrumental, PEGS Boston offered a tremendous opportunity for professional development."
Jackson B., Senior Research Scientist, New England Biolabs
"Excellent opportunity to hear about current innovations in the biologics field and network with knowledgeable experts in a smaller setting."
Jutta D., VP, R&D, Iksuda Therapeutics
"The growing understanding of the causes and development of diseases of all kinds is leading to increasingly complex protein-based therapies. If you want to maintain an overview of the field, attending the PEGS conference is a must"
Peter S., CEO & Cofounder, Tacalyx GmbH
"PEGS Boston is a must for anyone working in this industry."
Michael F., CSO, AbAb